Identification of an Immune-Related Prognostic Risk Model in Glioblastoma

Background: Glioblastoma (GBM) is the most common and malignant type of brain tumor. A large number of studies have shown that the immunotherapy of tumors is effective, but the immunotherapy effect of GBM is not poor. Thus, further research on the immune-related hub genes of GBM is extremely importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhiying, Wang, Rongsheng, Huang, Cuilan, He, Huiwei, Ouyang, Chenghong, Li, Hainan, Zhong, Zhiru, Guo, Jinghua, Chen, Xiaohong, Yang, Chunli, Yang, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247349/
https://www.ncbi.nlm.nih.gov/pubmed/35783263
http://dx.doi.org/10.3389/fgene.2022.926122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247349/
https://www.ncbi.nlm.nih.gov/pubmed/35783263
http://dx.doi.org/10.3389/fgene.2022.926122

Ejemplares similares